Healthcare Resource Utilization, Cardiovascular Event Rate and Use of Lipid-Lowering Therapies in Secondary Prevention of ASCVD in Hospitalized Patients in Italy.

Paolo SciattellaAldo P MaggioniEmanuela ArcangeliEduard SidelnikovDoreen A KahangireFrancesco S Mennini

Published in: Advances in therapy (2021)

This study found that CV events in secondary prevention Italian patients are associated with substantial HCRU and costs. More intensive LDL-C lowering can prevent CV events, easing the financial burden on the healthcare system.

Keyphrases

healthcare
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
fatty acid
social media